Expected US Company Earnings on Friday, February 6th, 2026

Biogen Inc. (BIIB) is expected to report $1.6 for Q4 2025

Frontier Group Holdings Inc. (ULCC) is expected to report $0.02 for Q4 2025

Johnson Outdoors Inc. (JOUT) is expected to report $-0.45 for Q1 2026

Piper Sandler Companies (PIPR) is expected to report $4.72 for Q4 2025

Ispire Technology Inc. (ISPR) is expected to report $-0.01 for Q2 2026

Proto Labs Inc. (PRLB) is expected to report $0.19 for Q4 2025

AutoNation Inc. (AN) is expected to report $4.91 for Q4 2025

Plains All American Pipeline L.P. (PAA) is expected to report $0.47 for Q4 2025

Canopy Growth Corporation (CGC) is expected to report $-0.03 for Q3 2026

Telenor ASA ADR (TELNY) is expected to report $0.24 for Q4 2025

Roivant Sciences Ltd. (ROIV) is expected to report $-0.38 for Q3 2026

Gorman-Rupp Company (The) (GRC) is expected to report $0.43 for Q4 2025

Ubiquiti Inc. (UI) is expected to report $2.78 for Q2 2026

Newell Brands Inc. (NWL) is expected to report $0.18 for Q4 2025

Coloplast AS ADR (CLPBY) is expected to report $0.09 for Q1 2026

Graham Corporation (GHM) is expected to report $0.17 for Q3 2026

PhenixFIN Corporation (PFX) is expected to report $0.39 for Q1 2026

MarketAxess Holdings Inc. (MKTX) is expected to report $1.66 for Q4 2025

Philip Morris International Inc (PM) is expected to report $1.67 for Q4 2025

Plains GP Holdings L.P. (PAGP) is expected to report $0.55 for Q4 2025

Virtus Investment Partners Inc. (VRTS) is expected to report $6.41 for Q4 2025

nVent Electric plc (NVT) is expected to report $0.89 for Q4 2025

Fujitsu Limited ADR (FJTSY) is expected to report $0.2 for Q3 2026

NioCorp Developments Ltd. (NB) is expected to report $-0.08 for Q2 2026

Under Armour Inc. Class A (UAA) is expected to report $-0.02 for Q3 2026

GrafTech International Ltd. (EAF) is expected to report $-1.26 for Q4 2025

Centene Corporation (CNC) is expected to report $-1.25 for Q4 2025

AerCap Holdings N.V. (AER) is expected to report $3.31 for Q4 2025

Immunovant Inc. (IMVT) is expected to report $-0.72 for Q3 2026

RXO Inc. (RXO) is expected to report $-0.04 for Q4 2025

Iterum Therapeutics plc (ITRM) is expected to report $-0.2 for Q4 2025

Carlyle Group Inc (The) - Ordinary Shares (CG) is expected to report $1.01 for Q4 2025